Drug purchases prior to conception and the risk of gestational diabetes mellitus

J Int Med Res. 2022 Nov;50(11):3000605221138455. doi: 10.1177/03000605221138455.

Abstract

Objective: Some drugs have adverse effects on glucose metabolism, but it is unknown whether prescription drugs used prior to conception influence the future risk of gestational diabetes mellitus (GDM). Our study evaluated whether the purchase of prescription drugs 6 months prior to conception was associated with the occurrence of GDM.

Methods: This cohort study enrolled women with a Finnish background who delivered between 2009 and 2015 in the city of Vantaa, Finland (N = 10,455). Data on maternal characteristics and prescription drug purchases were obtained from national health registers. The use of a unique personal identification number enabled us to combine the register data on an individual level.

Results: Six months prior to conception, women who had pregnancies complicated by GDM purchased more prescription drugs than women without GDM (1.38 ± 2.04 vs. 1.11 ± 1.80). The GDM risk was higher in women with higher numbers of prescription purchases and those with more than three deliveries.

Conclusions: Multiparous women who purchase several prescription drugs should be given personalized counseling to prevent GDM.

Keywords: Anatomical Therapeutic Chemical Classification System; Cohort study; counseling; drug purchase; gestational diabetes mellitus; glucose homeostasis; parity; prescription drug.

MeSH terms

  • Cohort Studies
  • Diabetes, Gestational* / drug therapy
  • Diabetes, Gestational* / epidemiology
  • Drug-Related Side Effects and Adverse Reactions*
  • Female
  • Humans
  • Parity
  • Pregnancy
  • Prescription Drugs* / adverse effects

Substances

  • Prescription Drugs